Article
22 Apr 2026
Biocon Launches Denosumab Biosimilars
AUTHORS CONTENT
Article
24 Mar 2026
Samsung Bioepis And Sandoz Expand Potential Portfolios Through New Research And Development Collaborations
Article
15 Jan 2026
Year In Review: Big Deals Of 2025
Article
18 Dec 2025
European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ
Article
12 Dec 2025
FDA Approves Lupin's Pegfilgrastim Biosimilar, ARMLUPEG
Article
10 Dec 2025
Amgen, Hikma, And Gedeon Settle Denosumab BPCIA Case
Article
06 Nov 2025
Prefilled Syringe Presentation Of GSK's SHINGRIX Receives Positive CHMP Opinion
Article
03 Nov 2025
Recent Biologics Decisions At Health Canada
Article
30 Sep 2025
FDA Approves Biocon's Denosumab Biosimilars
Article
26 Aug 2025
Alteogen's Aflibercept Biosimilar Receives Positive CHMP Opinion
Article
18 Jun 2025
Biosimilar Manufacturers To Expand Offerings In Europe And Japan
Article
19 May 2025
President Trump Issues Two Executive Orders Concerning The Affordability And Accessibility Of Drugs
Article
11 Apr 2025
GSK And Pfizer Stipulate To Dismissal Of RSV Vaccines Lawsuit
Article
10 Apr 2025
Accord Receives Positive EMA Opinion For Two Denosumab Biosimilars
Article
10 Apr 2025
EMA Seeks Input On A "Tailored Clinical Approach" In Biosimilar Development
Article
06 Mar 2025
European Commission Approves Celltrion's AVTOZMA (CT-P47)
Article
17 Jan 2025
Year In Review: Top Legal Developments Of 2024
Article
15 Jan 2025
Year In Review: Top Regulatory Developments Of 2024
Article
28 Oct 2024
GlaxoSmithKline And Northwestern Sue Moderna For Patent Infringement In Trio Of Lawsuits
Article
16 Aug 2024
Recent PTAB Developments For Regeneron's Aflibercept-Dosing Patents